Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,605 | 7,504 | 0 | 0 | 0 |
| Receivables | 5 | 9 | 0 | 0 | 0 |
| Other current assets | 775 | 1,475 | 0 | 0 | 0 |
| TOTAL | $47,384 | $8,988 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 55 | 30 | N/A | N/A | N/A |
| Other Non-Current Assets | 602 | 587 | 0 | 0 | 0 |
| TOTAL | $657 | $617 | $N/A | $N/A | $N/A |
| Total Assets | $48,041 | $9,604 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 44 | 23 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 882 | 962 | 0 | 0 | 0 |
| Other current liabilities | 1,096 | 769 | 0 | 0 | 0 |
| TOTAL | $2,327 | $2,115 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 678 | 716 | 0 | 0 | 0 |
| Deferred Revenues | 178 | 240 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 572 | 572 | 0 | 0 | 0 |
| TOTAL | $1,250 | $1,288 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,577 | $3,402 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,877 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -7,035 | -3,457 | 0 | 0 | 0 |
| Other shareholders' equity | -2,607 | -3,730 | 0 | 0 | 0 |
| TOTAL | $44,464 | $6,202 | $0 | $0 | $0 |
| Total Liabilities And Equity | $48,041 | $9,604 | $0 | $0 | $0 |